Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025 |
Resumo: | ABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility. |
id |
AMB-1_bb5c21494c43202ea476f109998134b0 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302016001200025 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic SyndromesMyelodysplastic SyndromeHematopoietic Stem Cell TransplantationPrognosisABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility.Associação Médica Brasileira2016-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025Revista da Associação Médica Brasileira v.62 suppl.1 2016reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.62.suppl1.25info:eu-repo/semantics/openAccessDuarte,Fernando BarrosoSantos,Talyta Ellen de Jesus dosBarbosa,Maritza CavalcanteKaufman,JacquesVasconcelos,João Paulo deLemes,Romélia Pinheiro GonçalvesRocha,Francisco DárioCoutinho,Diego FerreiraZalcberg,IlanaVasconcelos,Paulo Roberto Leitão deeng2016-12-01T00:00:00Zoai:scielo:S0104-42302016001200025Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2016-12-01T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
title |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
spellingShingle |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes Duarte,Fernando Barroso Myelodysplastic Syndrome Hematopoietic Stem Cell Transplantation Prognosis |
title_short |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
title_full |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
title_fullStr |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
title_full_unstemmed |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
title_sort |
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes |
author |
Duarte,Fernando Barroso |
author_facet |
Duarte,Fernando Barroso Santos,Talyta Ellen de Jesus dos Barbosa,Maritza Cavalcante Kaufman,Jacques Vasconcelos,João Paulo de Lemes,Romélia Pinheiro Gonçalves Rocha,Francisco Dário Coutinho,Diego Ferreira Zalcberg,Ilana Vasconcelos,Paulo Roberto Leitão de |
author_role |
author |
author2 |
Santos,Talyta Ellen de Jesus dos Barbosa,Maritza Cavalcante Kaufman,Jacques Vasconcelos,João Paulo de Lemes,Romélia Pinheiro Gonçalves Rocha,Francisco Dário Coutinho,Diego Ferreira Zalcberg,Ilana Vasconcelos,Paulo Roberto Leitão de |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Duarte,Fernando Barroso Santos,Talyta Ellen de Jesus dos Barbosa,Maritza Cavalcante Kaufman,Jacques Vasconcelos,João Paulo de Lemes,Romélia Pinheiro Gonçalves Rocha,Francisco Dário Coutinho,Diego Ferreira Zalcberg,Ilana Vasconcelos,Paulo Roberto Leitão de |
dc.subject.por.fl_str_mv |
Myelodysplastic Syndrome Hematopoietic Stem Cell Transplantation Prognosis |
topic |
Myelodysplastic Syndrome Hematopoietic Stem Cell Transplantation Prognosis |
description |
ABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.62.suppl1.25 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.62 suppl.1 2016 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212832343228416 |